| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_588a9f6f9644c092450c1efd7bf33375
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4ce5d7d5a27a23b825368afa473ed58c |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-33 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-8146
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-12 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-81
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-62 |
| filingDate |
2019-01-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_11db6868a6ce68b7792b6056dcaa8df7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1156b0540077162e0f7227a5be9d888b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_713bad0fc5872841ffafe6e45cbf2e4e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0a1a72cb47f30e7694843229207d7e1b |
| publicationDate |
2020-12-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-3743439-A1 |
| titleOfInvention |
Use of a peptide derived from the human protein ntimp3 in the treatment of diabetic nephropathy |
| abstract |
The present invention relates to fusion peptides consisting of the peptide fragment corresponding to the N-terminal domain derived from the human TIMP3 protein, both in native and mutated form, bound by the N-terminal end to a highly selective and efficient carrier peptide for transport in renal proximal tubule cells, the medical use thereof, in particular the use thereof in the treatment of diabetic nephropathy, and the compositions comprising them. |
| priorityDate |
2018-01-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |